Expert Insights from Health IT Industry Analysts
The Chilmark Research blog is the foundation of the analyst firm. Weekly blogging is how our founder first established credibility in the industry all the way back in 2007, becoming a core platform for industry discussion and engagement since those early days. You can see how our subject matter experts are viewing developing technology use cases, the narratives surrounding their adoption and regulation, and engage with this coverage directly in the comments. Click through any of the articles below to see what’s new!
Three Big Questions for Stage 3 & Patient Engagement
For many, the delay of Stage 3 of the Meaningful Use program evoked a collective sigh of relief, providing a much-needed extra year to focus on the challenging requirements for patient engagement and interoperability. As distant as 2017 may seem however, the...
Payers Refocus Efforts on ROI for Member Engagement
What a difference a year has made to the payer market. In late 2012 Chilmark Research published the first version of our Payer Benchmark report -- detailing how leading payers were beginning to adopt emerging consumer technologies. We found a market where significant...
What’s in Store for 2014?
That time of year once again where we collectively look into our crystal ball, or throw the sticks or maybe even look at the coffee grinds dripping down the sides on our coffee cup to see what may be in the year to come. Making these predictions for the coming year is...
Looking Ahead to Data Visualization & Blazingly Fast Database Technology
Last week I attended the annual Data Warehousing (TDWI) event in Orlando. This is a fantastic, intimate setting of the top experts, and plenty of novices, in data warehousing and analytics. The event is totally focused on education, with only a small amount of vendor...
mHealth13: Lots Going On, But Few New Developments
Another year, another mHealth Summit. HIMSS’ younger sibling has slowly grown over the last five years, a period that has seen a Precambrian explosion of companies and advances in mobile tech. However, despite some early hints of maturity, the mHealth Summit revealed...
The Two Faces of Population Health Management
As we head into the New Year, we at Chilmark Research have been thinking a lot about how we will approach Population Health Management (PHM) in 2014, and beyond. PHM is actually a pretty unfortunate term for the data-driven business processes and associated tech stack...
Time to Move Beyond HIE
Our ongoing coverage of the HIE industry leads us to the question of what clinicians do after getting connected to an HIE? To this end, we are conducting a 10-minute web survey on clinician’s experiences using HIEs for care coordination. We want to understand how...
23andMe vs the FDA: How did it come to this?
As most of our readers are likely aware, the FDA this week issued a scathing letter effectively prohibiting the 5 year-old, 23andMe personal genomics testing company from doing business. Quite frankly, this is all pretty unnecessary, and reflects poor policy on...
Whose Data is it Anyway?
A common and somewhat unique aspect to EHR vendor contracts is that the EHR vendor lays claim to the data entered into their system. Rob and I, who co-authored this post have worked in many industries as analysts. Nowhere, in our collective experience, have we seen...
Subscribe to the Chilmark Newsletter
Stay up to date with the latest healthcare IT news!